Corporate News     18-Jan-23
Tanla Platforms extinguished 14.16 lakh equity shares
Tanla Platforms has bought back 14,16,666 equity shares pursuant to the Buyback and the same have been extinguished in compliance with Regulation 11 of the SEBI Buyback Regulations.
Previous News
  Tanla Platforms launches Registration.ai on Trubloq
 ( Corporate News - 28-Aug-24   09:55 )
  Tanla Platforms consolidated net profit rises 34.85% in the June 2023 quarter
 ( Results - Announcements 20-Jul-23   17:03 )
  Tanla Platforms to hold AGM
 ( Corporate News - 08-Aug-23   19:30 )
  Volumes soar at Tanla Platforms Ltd counter
 ( Hot Pursuit - 10-Jan-24   11:00 )
  Tanla Platforms to announce Quarterly Result
 ( Corporate News - 30-Jul-22   12:03 )
  Tanla Platforms update on contract with Vodafone Idea
 ( Corporate News - 18-Aug-23   18:44 )
  Tanla Platforms announces board meeting date
 ( Corporate News - 10-Jul-24   17:45 )
  Volumes jump at Tanla Platforms Ltd counter
 ( Hot Pursuit - 26-Jul-22   11:00 )
  Tanla Platforms to discuss results
 ( Corporate News - 12-Jan-23   10:24 )
  Tanla Platforms announces incorporation of step-down subsidiary
 ( Corporate News - 03-Jul-21   15:10 )
  Board of Tanla Platforms recommends Final Dividend
 ( Corporate News - 20-May-21   11:14 )
Other Stories
  Hinduja Global Solutions opens new CX hub in Cape Town, South Africa
  03-Oct-24   10:13
  Anmol India to conduct board meeting
  03-Oct-24   10:07
  KPI Green Energy receives CEIG approval for 5 MW solar power project
  03-Oct-24   10:04
  Navkar Corporation revises board meeting date
  03-Oct-24   09:52
  Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
  03-Oct-24   09:52
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
Back Top